| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5824955 | Clinical Therapeutics | 2016 | 13 Pages |
Abstract
Pixantrone may be considered both clinically effective and cost-effective for patients with multiply relapsed or refractory aNHL who currently have a high level of unmet need.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Noemi MSc, Ananth PhD, Tereza MSc, Anthony J. MSc, Dilip BSc, Lixia PhD, Jack W. MD, Ruth PhD,